Circular RNA (CircRNA) is an endogenous noncoding RNA with covalently closed cyclic structure. It is divided into exonic circRNA, intronic circRNA and exon-intron circRNA, based on their components. CircRNAs are well conserved in sequence and abundantly expressed in a tissue specific manner. They have a high stability due to resistance to exonuclease.
112 derived from pre-mRNAs and they regulate their own gene expression predominantly at post-113 transcription level [31] and only few of them regulate transcription [7] Generally, circRNA show 114 tissue-specific and/or developmental-stage-specific expression pattern similar to that of 115 corresponding linear mRNA targets, and their expression level is >10 times higher than of the 116 linear mRNA [14] [32]. CircRNAs exist and detectable in many types of extracellular body fluids, 117 such as saliva, blood, and urine [33] [14] . More than 400 circRNA have been found in human 118 cell-free saliva (CFS) from healthy individuals [34] . CircRNAs show evolutionarily conserved 119 sequence features across different species [35] . The covalently closed loop structures with lack 120 of 5'-3' polarity and without polyadenylated tail fovours resistance to RNA exonuclease 121 degradation [36] . CircRNAs play diverse biological roles due to the fact that average half-life of 122 circRNA in most species is much longer than its linear counterpart [32, 34] . circRNAs have a variety of functions including miRNA sponging activity, modulation of 125 alternative splicing or transcription, regulating the expression of parental genes, interaction 126 with RBPs and alter their activity, rolling circle translation and generate pseudogenes. 127 
1 CricRNA as MiRNA Sponges

128
CircRNAs act as a competing endogenous RNAs (ceRNA) that contain shared miRNA 129 response elements (MRE) by which they sequestering miRNAs and preventing their interactions 130 with target mRNAs (Fig. 3a) . The systematically validated circRNAs such as circRNA such as ciRS-131 7 (CDR1as) [18, 32] and Sry circRNA(circSry) [18, 37] are produced from the mRNAs of cerebellar 132 degeneration associated protein 1 (CDR1) and dysregulated rat testis SRY respectively. During 133 embryonic developmental process in zebrafish, the expression of CDRlas reduces the brain 134 volume and its development is hampered. However, the exogenous delivery of miR-7 can bring 135 the brain volume and development to normal, which illustrate that CDRlas blocks miR-7 by 136 CircRNAs participate in the regulation of alternative splicing and transcription, and thereby 150 they control gene expression (Fig. 3b) . For example, circMbl is generated from the second exon 151 of the splicing factor MBL, which competes with canonical premRNA splicing. circMbl and its 152 In eukaryotic cells, the cyclic mRNA can be translated by typical translation machineries 177 due to the fact that it contains an IRES (internal ribosome entry site) sequence and it can bind 178 directly to the ribosome (Fig. 3d) . In prokaryotic cells such as E. coli, the circRNA contains a well 179 conserved ORF (infinite open reading frame) system, which enables the translation of 180 circularised RNA [48] . In eukaryotic system, the some circRNAs have binding sites for ribosomal 181 40S subunits, thus it can initiate the translation. This was proved in both in vivo and in vitro 182 studies. In E. coli system, the circRNA with an insertion of GFP (green The human genome array, 133plus2.0 tool, can detect mRNA, but it does not able to detect 246 the ring RNA because the probe is designed for linear RNA. So it cannot effectively distinguish 247 cyclic RNA and linear RNA, when normal probe is used. However, if the probe is designed based 248 on the reverse splice site of the circRNA, this array tool specifically detect circRNA, as there is 249 no reverse splice site sequence on the linear RNA. In this way, it can effectively distinguish 250 circular RNA and mRNA. The field of circRNA research gaining more attention recently due to the fact that they 253 contribute to many physiological as well as pathological processes. Unlike conventional PCR 254 primers, the designing of the circRNA primers should consider the following criteria: For the 255 detection of exonic circRNA, the primers for cross-cut site (backsplice) should be designed. In 256 the case of intron cyclized cyclRNAs, the primers targeting cross-cleavable sites should be used. 257 The primers can also be designed around intron regions. The length of the amplified product 258 should not be more than 100 bp. The squence position transformation is also important. The 259 difference in selection of primers for linear RNA and circRNA is given in Fig. 4. 
260
The actual amplification effect after primer design needs to be experimentally determined. 261 If the quantification of circRNA is carried out by qPCR, the length of amplification should be 262 settled according to the experimental requirements of qPCR. Thus, qPCR remains the most 263 widely used technique to assess the expression level of circRNA. 264 
2 The Database in CircRNA Research
265
In recent years, the number of cirRNA research tools is rapidly increasing with different 266 aspects and improved functional analysis. Here, we present currently available online databases 267 for the detection and characterization of circRNA, which contain GenBank annotations or 268 circRNA from published articles. Each database analyses cricRNA with different characteristics 269 features feeded for the detection and they provide much information about circRNA. There are 270 several free online databases available for the circRNA research (Table 3) . CircRNAs have the characteristics of conserved sequence, tissue specificity, more stability 273 and high abundance of expression, which enables them to be potential markers for disease 274 screening and treatment. The rapid development of high throughput sequencing techniques 275 and bioinformatic analyses suggest that it is likely to become a new efficient target in the 276 clinical settings for the detection and treatment of diseases such as diabetes, cancer, 277 cardiovascular disease and neurological diseases. It is notable that circRNAs could function as 278 miRNA sponges and regulating multiple signaling pathways in the cardiovascular diseases, 279 different types of cancer, neurodegenerative diseases and diabetes. However, further 280 researches are needed to reveal the complete biological functions of of circRNA in terms of 281 both physiological and pathological processes so that it can be applied to clinical use in future. 282 Despite the rapid advancement has been in the detection and characterization of circRNA, 283 the knowledge about the functions of circular RNA is still at an early stage, which is one of the 284 major drawbacks for the potential use of circRNA for therapeutic or diagnostic purposes. The 285 new generation methods such as chip technology can be used to screen the possible disease-286 related circRNA in the cell or experimental animal models. This will increase our knowledge 287 about the role of circRNA in the occurrence and development of pathological disorders. In 288 addition to deepening the circRNA research in functional aspects, the someother questions 289 should also to be refined. For example, how the dynamics of the circRNA formation is triggered 290 and controlled? What is the link between circRNA formation process and the corresponding 291 linear RNA generation? What is the relationship between different circRNA products from the 292 same gene? How is the circRNA generation precisely regulated? The identification and 293 characterisation of specific circRNA interacting molecules is important to answer most of these 294 fundamendal questions. In addition, the naming of circRNA has not yet been unified and the 295 mechanisms of circRNA in many diseases are not clear. By solving all these questions, circRNA 296 could be a promising diagnostic tool for the detection and efficient therapeutic targets for 297 treatment of various pathological disorders. 
Cardiac senescence
CircFoxo3
Circ-Foxo3 is generated from Foxo3. Its expression is highly correlate with markers of cellular senescence [56] and circ-Foxo3 represses cell cycle progression and cell proliferation [57] , it interacts with several transcription factors (E2F1, FAK, and HIF1a) and anti-senescent protein such as ID-1 and preventing their nucleus entry, which repress their anti-senescence roles, circ-Foxp3 also positively correlates with cellular senescence [56].
Cdr1as
Cdr1as promotes apoptosis and MI injury by blocking the activity of mir7a and increasing the expression of mir-7a targets such as PARP and SP1[58-60].
Cardiov ascular Diseases
Myocardial Infarction(
MFACR MFACR dependent inhibition of mir-652-3p increases MTP18 and mitochondrial fission, which results in reduction of cardiomyocyte apoptosis and extension of MI injury [61] .
Neurodegenerative Diseases
CDR1as
In lead-induced neuronal apoptosis, circRar1 can directly inhibit miR-671, which leads to the suppression of Akt2 and increased expression of Caspase-8 and other apoptosis-related proteins [62] .
Osteoarthritis (OA)
Hsa_circ_ 0005105 It promotes extracellular matrix (ECM) degradation by regulating the expression of mir-26a target NAMPT [63] .
Major depressive disorders (MDD).
Hsa_circR NA_1036 36
It is easily detectable in blood samples and its expression pattern altered in MDD [64] .
Silicosis
CircHECT D1
It mediates silica-induced macrophage activation via HECTD1/ZC3H12A-dependent ubiquitination [65] .
Diabetes
Cdrlas
The impairment of Islet β-cell function leads to a absolute or relative insulin deficiency (insulin resistance), which causes increase in blood sugar level and diabetes [66,67], mir-7 negatively regulates the proliferation of islet β cells and targets multiple components of mammalian target of ripamycin (mtor) signaling pathway, which are involved in pancreatic β cell proliferation, these finding reveal that CDR1as/mir-7 could be a potential therapeutic target for treating and managing diabetes [68].
Hsa-circ-002059
The increased expression of Hsa-circ-002059 is significantly associated with the tumor stage of GC [69] . 
Cancer
